Replies to post #546130 on NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Again, IMO it was and still is way too early to give management bonuses equal to more that 10% of the outstanding shares in the company, based on what? I've been as optimistic (and forgiving of this taking forever because I have no choice) as anybody, but really what do we have as of now let alone as of YE 2020 when these bonuses were granted? We have nothing but bliind trust, OK an educated guess that they can get approved. Even with approval there is a lot of execution still ahead to be negotiated. So far, we're not at any proof-positive endpoint and it's taken a hell of a long time to get here.

Longs should be a lot more hard-headed about very rich compensation before we've actually got the damn goods delivered. Are you all ready to give management another 10% of all shares outstanding when they finally get RA approval and then another 10% when they prove they can actually ramp up and deliver product to all patients who want it? It's a lot more likely than not that they will expect further risk rewards based on how much they've demanded for so little actually in our hands to date (again the bonuses are for as of YE 2020 for Pete's sake).

This is just way too generous, way too soon. The 2020s are not a decade where management should be getting prepaid for results on the basis of hard work alone and promise of eventual revenues with actual delivery still remaining to be seen. Well clearly from all the wild-eyed enormous expectations, too many longs have been counting hope of huge numbers of chickens far too long. Especially those who have been around more than 5 years should have modest expectations until we start treating patients and getting paid for it, and I can't see rewarding management more than 10% of the company because we hope they will make us a lot of money eventually. I never got paid any bonuses for developing products before they were actually available!

Why oh why are the bonuses not 'pay as we go' when our money is still at risk with the real and actual value remaining to be demonstrated? Waay too much blind trust imo and way too willing to heap on 8-digit bonuses as prepayment for what still has not even started to pay off.